In a filing, Blueprint Medicines Corp revealed its CHIEF OPERATING OFFICER Rossi Christina unloaded Company’s shares for reported $0.22 million on Feb 20 ’25. In the deal valued at $95.14 per share,2,274 shares were sold. As a result of this transaction, Rossi Christina now holds 64,835 shares worth roughly $6.0 million.
Then, Haviland Kate sold 1,446 shares, generating $159,407 in total proceeds. Upon selling the shares at $110.24, the CHIEF EXECUTIVE OFFICER now owns 149,378 shares.
Before that, Rossi Christina sold 2,274 shares. Blueprint Medicines Corp shares valued at $250,455 were divested by the CHIEF OPERATING OFFICER at a price of $110.14 per share. As a result of the transaction, Rossi Christina now holds 67,109 shares, worth roughly $6.21 million.
JP Morgan initiated its Blueprint Medicines Corp [BPMC] rating to an Overweight in a research note published on November 14, 2024; the price target was $126. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Neutral”‘ rating. Stephens began covering BPMC with “an Overweight” recommendation on May 14, 2024. Leerink Partners revised its rating on May 06, 2024. It rated BPMC as “a Market perform” which previously was an “an Underperform”.
Price Performance Review of BPMC
On Friday, Blueprint Medicines Corp [NASDAQ:BPMC] saw its stock jump 0.25% to $92.48. Over the last five days, the stock has lost -1.55%. Blueprint Medicines Corp shares have risen nearly 6.03% since the year began. Nevertheless, the stocks have risen 5.98% over the past one year. While a 52-week high of $121.90 was reached on 01/27/25, a 52-week low of $80.42 was recorded on 01/10/25. SMA at 50 days reached $99.46, while 200 days put it at $98.57.
Levels Of Support And Resistance For BPMC Stock
The 24-hour chart illustrates a support level at 91.09, which if violated will result in even more drops to 89.69. On the upside, there is a resistance level at 94.06. A further resistance level may holdings at 95.63. The Relative Strength Index (RSI) on the 14-day chart is 34.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -7.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.44%. Stochastics %K at 8.67% indicates the stock is a buying.
